Advisory Board
The LSM advisory board is designed to bring together industry leaders, scientific and medical experts, and corporate executives who can provide guidance and feedback on both curricular and co-curricular aspects of the program.
Current members of the advisory board include:
Arie Belldegrun, M.D. (PAR'05, PAR'08)
Professor of Urology
Chief, Division of Urologic Oncology
Roy and Carol Doumani Chair in Urologic Oncology
UCLA School of Medicine
Robert Benz, M.D. (C'74, PAR'05, PAR'06)
President
Main Line Health
David Blumberg (WG'90)
Principal and Advisory Sector Leader - Pharmaceuticals
KPMG LLP
Robert Doms, M.D., Ph.D.
Chair, Department of Microbiology
University of Pennsylvania
Benjamin Doranz, Ph.D. (GR'98, WG'01)
President and Chief Scientific Officer
Integral Molecular
David Elliman (C'73, WG'77)
Chairman
Elmrock Capital, Inc.
Garret FitzGerald, M.D.
Professor of Medicine and
Chair, Department of Pharmacology
University of Pennsylvania
M. Therese Flaherty, Ph.D.
Director
Wharton Small Business Development Center
Sarah Fuller (CW'71, PAR'04, PAR'07)
President
Decision Resources, Inc.
Joshua Kazam (W'99)
Partner
Two River Group Holdings
John King II (C'74, PAR'04, PAR'09)
Former Senior Vice President, Research Planning & Integration
Merck Research Laboratories
Steven Nichtberger, M.D. (C'83, W'83)
President, Chief Executive Officer, Director
Tengion, Inc.
Paul Offit, M.D.
Chief of Infectious Diseases
Children’s Hospital of Philadelphia
Swati Piramal, M.B.B.S. (PAR'06)
Director, Strategic Alliances & Communications
Piramal Life Sciences
Douglas Ringler, VMD (C'79, V'83)
Chief Executive Officer
Tolerx, Inc.
Barbara Schilberg
Managing Director & Chief Executive Officer
BioAdvance
Martin Silverstein, M.D. (C'76)
Senior Partner and Managing Director
Global Leader - Health Care Practice
Boston Consulting Group
Kuo Tong
President and Founder
Quorum Consulting
P. Roy Vagelos, M.D. (C'50) - honorary member
Retired Chair of the Board and Chief Executive Officer
Merck & Co.